Category Archives : News

Home  >>  News

Heidelberg University: DFG grants millions for lipid research and research in plant processes

On November 28, 2017, Posted by , In News,Press Releases, With Kommentare deaktiviert für Heidelberg University: DFG grants millions for lipid research and research in plant processes

The Collaborative Research Centre/Transregio 83 “Molecular Architecture and Cellular Functions of Lipid/Protein Assemblies”, a joint network in lipid research of the universities of Heidelberg, Dresden, and Bonn, will continue its work in a third funding period. After a successful evaluation, the German Research Foundation (DFG) has approved funds of about…

BioMed X and Boehringer Ingelheim start new joint research group in bacterial modulation of innate immunity

On November 22, 2017, Posted by , In News,Press Releases, With Kommentare deaktiviert für BioMed X and Boehringer Ingelheim start new joint research group in bacterial modulation of innate immunity

Heidelberg, Germany, November 22, 2017 – BioMed X announced today the start of a new joint research group with Boehringer Ingelheim at the BioMed X Innovation Center in Heidelberg. The focus of the group will be to identify novel regulatory pathways within the innate immune system, through understanding molecular mechanisms…

EMBL: High-res Ebola model could spark new questions

On November 15, 2017, Posted by , In News,Press Releases, With Kommentare deaktiviert für EMBL: High-res Ebola model could spark new questions

High-res Ebola model could spark new questions By peering into the strands of the Ebola virus (pictured here), researchers were able to create a 3D model of the nucleocapsid. IMAGE: NIAID (CC BY 2.0) EMBL researchers create highest resolution 3D model of important structure within Ebola virus Although the ravages…

Technology Park Heidelberg: Life Science Accelerator-Teams belegen ersten und zweiten Platz des Hightech-Award CyberOne

On November 15, 2017, Posted by , In News,Press Releases, With Kommentare deaktiviert für Technology Park Heidelberg: Life Science Accelerator-Teams belegen ersten und zweiten Platz des Hightech-Award CyberOne

Life Science Accelerator-Teams belegen ersten und zweiten Platz des Hightech-Award CyberOne Gewinner CyberOne (Bild: Eva-Maria Markutzik) Am Montagabend wurde der Hightech-Preis CyberOne im Europapark Rust verliehen. Der Preis zählt zu den begehrtesten Auszeichnungen des Landes Baden-Württemberg für Hightech-Gründer. Zwei der vom Life Science Accelerator geförderten Teams überzeugten die Jury mit…

Hummingbird Diagnostics GmbH and Saarland University Collaborate in Early Disease Detection Based on Molecular Markers

On November 14, 2017, Posted by , In Allgemein,News,Press Releases, With Kommentare deaktiviert für Hummingbird Diagnostics GmbH and Saarland University Collaborate in Early Disease Detection Based on Molecular Markers

miRNA Experts Sign Framework Agreement HEIDELBERG and SAARBRÜCKEN, November 14, 2017 – Hummingbird Diagnostics GmbH, specialized in early disease detection using molecular markers derived from blood, and Saarland University agreed on a comprehensive framework agreement regarding an expanded collaboration in the field of molecular diagnostics. The work aims at the…

Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases

On November 10, 2017, Posted by , In News,Press Releases, With Kommentare deaktiviert für Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases

Collaboration and licensing agreement focused on investigating up to three targets and has a potential transactional value of up to EUR 307 million, excluding royalties Expands Boehringer Ingelheim’s comprehensive R&D programme in non-alcoholic steatohepatitis (NASH) and fibrotic liver disease with innovative novel treatment modalities Leverages MiNA’s leading expertise in RNA…

DKFZ: Rare pancreatic cancer reveals targets for therapy

On November 8, 2017, Posted by , In News,Press Releases, With Kommentare deaktiviert für DKFZ: Rare pancreatic cancer reveals targets for therapy

Scientists from the German Cancer Research Center (DKFZ) have conducted comprehensive molecular analyses of a rare type of pancreatic cancer. They have discovered a variety of cellular alterations that can be targeted by drugs that are already available and in part even already approved for therapy. Malignant growths in the…

DKFZ: Sixty-five new genetic risk markers for breast cancer discovered

On Oktober 25, 2017, Posted by , In News, With Kommentare deaktiviert für DKFZ: Sixty-five new genetic risk markers for breast cancer discovered

Until now, familial breast cancer has only partly been linkable to genetic risk markers. In a worldwide joint effort, researchers have now identified further genetic variants that affect the risk for breast cancer. The study, which was conducted with participation of researchers from the German Cancer Research Center (DKFZ) and…

DKFZ: Therapies for older leukemia patients

On August 8, 2017, Posted by , In News,Press Releases, With Kommentare deaktiviert für DKFZ: Therapies for older leukemia patients

The German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) will provide funding for a new research group at the German Cancer Research Center (DKFZ) and at the University of Freiburg and Freiburg University Medical Center. The scientists will jointly pursue fundamental and clinical research into acute myeloid leukemia (AML). The DFG will…

DKFZ: Cancer cells put the brakes on immune system

On August 8, 2017, Posted by , In News,Press Releases, With Kommentare deaktiviert für DKFZ: Cancer cells put the brakes on immune system

In order for cancer cells to successfully spread and multiply, they must find a way to avoid the body’s own immune system. Scientists at the German Cancer Research Center (DKFZ) have published an explanation for how this occurs with chronic lymphatic leukemia (CLL). The degenerated cells cause an inflammatory reaction…